Oncology

Drug Name

• ABECMA
• ABRAXANE
• Active Surveillance for Low-Risk Prostate Cancer Safe for Younger Men
• ADCETRIS
• Adjuvant Chemo After Nephroureterectomy May Aid Survival in UTUC
• Adjuvant Radiation Therapy Beneficial in Advanced UTUC
• Advanced, Fatal Prostate Cancer Linked to High Visceral Fat
• AFINITOR
• AFINITOR DISPERZ
• Agent Orange Possibly Protective in Prostate Cancer ADT Recipients
• ALECENSA
• ALIMTA
• ALIQOPA
• ALUNBRIG
• ALYMSYS
• ARIMIDEX
• AROMASIN
• ARRANON
• ARZERRA
• ASPARLAS
• AVASTIN
• AZEDRA
• BALVERSA
• BAVENCIO
• BELEODAQ
• BENDEKA
• BESPONSA
• BESREMI
• BEXXAR
• BICNU
• Biopsy, Pathology Results Often Differ in UTUC
• Biparametric MRI May Suffice for Prostate Cancer Detection
• Bladder Cancer Risk Elevated in Statin Users
• Bladder Cancer, UTUC More Common in Kidney Transplant Recipients
• BLENREP
• Bleomycin
• BLINCYTO
• BOSULIF
• BRAFTOVI
• BREYANZI
• BRUKINSA
• BUSULFEX
• BYNFEZIA PEN
• CABOMETYX
• CALQUENCE
• CAMCEVI
• CAMPATH
• CAPRELSA
• Carboplatin
• CARVYKTI
• CASODEX
• CERUBIDINE
• Cisplatin
• CKD Is a Risk Factor for UTUC
• Cladribine
• CLOLAR
• COMETRIQ
• COPIKTRA
• COSELA
• COSMEGEN
• COTELLIC
• CRPC Linked to Increased Risk for Second Primary Malignancies
• Cyclophosphamide
• Cyclophosphamide Injection
• CYRAMZA
• Cytarabine
• Dacarbazine
• DACOGEN
• DANYELZA
• Darolutamide Granted Priority Review Status for nmCRPC
• DARZALEX
• DARZALEX FASPRO
• DAURISMO
• Degree of Hydronephrosis Predicts Urothelial Carcinoma (UTUC) Outcomes
• DELESTROGEN
• DEPO-PROVERA
• DEPOCYT
• DOXIL
• Doxorubicin HCl
• Doxorubicin HCl Solution
• EFUDEX
• EFUDEX CREAM
• ELAHERE
• ELIGARD
• ELLENCE
• ELZONRIS
• EMCYT
• EMPLICITI
• ENHERTU
• ERBITUX
• ERIVEDGE
• ERLEADA
• ERWINAZE
• ESTRACE
• ETHYOL
• ETOPOPHOS
• Etoposide Capsules
• EVISTA
• EVOMELA
• EXKIVITY
• FARESTON
• FARYDAK
• FASLODEX
• FDA Approves New First-Line Treatment for Advanced RCC
• FEMARA
• FIRMAGON
• Fludarabine
• Fluorouracil
• Flutamide
• FOLOTYN
• FOTIVDA
• FUSILEV
• FYARRO
• GAVRETO
• GAZYVA
• Gemcitabine
• GILOTRIF
• GLEEVEC
• GLEOSTINE
• GLIADEL
• HALAVEN
• HERCEPTIN
• HERCEPTIN HYLECTA
• HERZUMA
• High Gleason Pattern at PSM Ups Prostate Cancer Relapse Risk
• Higher Vitamin D Levels Reduce the Likelihood of Kidney Cancer
• HYCAMTIN
• HYCAMTIN CAPSULES
• HYDREA
• IBRANCE
• ICLUSIG
• IDAMYCIN PFS
• Idarubicin
• IDHIFA
• IFEX
• IMBRUVICA
• IMBRUVICA TABLETS
• IMFINZI
• IMLYGIC
• INFUGEM
• INLYTA
• INQOVI
• INREBIC
• INTRON A
• INTRON A SOLN
• IRESSA
• ISTODAX
• IXEMPRA
• JAKAFI
• JAYPIRCA
• JELMYTO
• JEMPERLI
• JEVTANA
• KADCYLA
• KANJINTI
• KEPIVANCE
• KEYTRUDA
• KHAPZORY
• Kidney Cancer Linked to Adolescent Overweight, Obesity
• Kidney Stones Up Kidney Cancer Risk
• KIMMTRAK
• KISQALI
• KISQALI FEMARA CO-PACK
• KOSELUGO
• KOSELUGO
• KRAZATI
• KYMRIAH
• KYPROLIS
• LENVIMA
• Leucovorin
• LEUKERAN
• Leuprolide acetate
• LEVOXYL
• LIBTAYO
• Long-Term PCa Treatment Outcomes Superior With Radiation Plus ADT
• Long-Term Use of Low-Dose Aspirin May Lower PCa Mortality
• LORBRENA
• LUMOXITI
• LUNSUMIO
• LUPRON DEPOT 7.5mg
• LUPRON DEPOT-3 MONTH 22.5mg
• LUPRON DEPOT-4 MONTH 30mg
• LUPRON DEPOT-6 MONTH 45mg
• LUTATHERA
• LYNPARZA
• LYSODREN
• MARGENZA
• MARQIBO
• MATULANE
• Megestrol Tablets
• MEKINIST
• MEKTOVI
• Melphalan
• Melphalan Injection
• MENEST
• Mercaptopurine
• MESNEX
• MESNEX INJECTION
• Metastasis Site Affects Risk of Dying From Testicular Germ Cell Cancer
• Methotrexate for Injection
• Methotrexate Injection
• Methotrexate Tablets
• Mitomycin
• Mitomycin Gel Granted Breakthrough Status for Urothelial Cancer
• Mitoxantrone HCl
• MVASI
• MYLERAN
• Neoadjuvant Chemo May Lower Risk of UTUC Recurrence in the Bladder
• NERLYNX
• NEXAVAR
• NILANDRON
• NINLARO
• No Surgery in Nearly 11% of Localized UTUC Cases
• NUBEQA
• ODOMZO
• OGIVRI
• ONCASPAR
• ONIVYDE
• ONTAK
• ONTRUZANT
• OPDIVO
• OPDUALAG
• ORGOVYX
• ORSERDU
• Paclitaxel
• PADCEV
• Pamidronate Disodium Injection
• PEDMARK
• PEMAZYRE
• PEMFEXY
• Pentostatin
• PERJETA
• PHOTOFRIN
• PIQRAY
• PLUVICTO
• POLIVY
• POMALYST
• PORTRAZZA
• POTELIGEO
• PREMARIN
• PROGLYCEM SUSPENSION
• PROLEUKIN
• Prostate Cancer Death Risk Lower With Statin Use After ADT Start
• Prostate Cancer Incidence Dropping, Stable in Most Countries
• Prostate Cancer Mortality Lowest With Radical Prostatectomy
• Prostate mpMRI May Be Helpful in the Neoadjuvant PCa Therapy Setting
• PROVENGE
• PURIXAN
• QUADRAMET
• Radical Surgery for Metastatic Prostate Cancer Results in Greater Morbidity
• RCC Tumor Size Affects PN, Cryoablation Survival Outcomes
• Renal Ultrasound Appropriate for Initial Upper Tract Evaluation
• RETEVMO
• REVLIMID
• REZLIDHIA
• RIABNI
• RITUXAN
• RITUXAN HYCELA
• Robotic Partial Nephrectomy May Be a Viable Option for Large Renal Tumors
• ROZLYTREK
• RUBRACA
• RUXIENCE
• RYDAPT
• SANDOSTATIN
• SANDOSTATIN LAR DEPOT
• SARCLISA
• SCEMBLIX
• SENSIPAR
• SOLTAMOX
• SOMATULINE DEPOT
• SPRYCEL
• Standard of Care for mRCC May Change
• SUTENT
• SYLATRON
• SYNRIBO
• SYNTHROID
• TABRECTA
• TAFINLAR
• TAGRISSO
• TALZENNA
• Tamoxifen
• TARCEVA
• Targeted RCC Therapies Benefit ‘Real World’ Medicare Patients
• TARGRETIN
• TARGRETIN GEL
• TASIGNA
• TAXOTERE
• TAZVERIK
• TECARTUS
• TECENTRIQ
• TECVAYLI
• TEMODAR
• TEMODAR INJECTION
• Teniposide
• TEPADINA
• TEPMETKO
• Testosterone Enanthate
• THALOMID
• Thioguanine
• Thiotepa
• THYQUIDITY
• THYROGEN
• TIBSOVO
• TICE BCG
• Time from Definitive Therapy to ADT Predicts mCRPC Risk
• TIROSINT-SOL
• TIVDAK
• TOPOSAR
• TORISEL
• TOTECT
• TRAZIMERA
• TREANDA
• TRELSTAR
• Tretinoin
• TREXALL
• TRISENOX
• TRODELVY
• TRT Reduces Post-RARP Recurrence Risk in Low-Risk Prostate Cancer
• TRT Speeds Potency Recovery After Prostate Surgery
• TRUXIMA
• TUKYSA
• TURALIO
• TYKERB
• Unique Drug Cuts CRPC Mets Risk
• UNITHROID
• UNITUXIN
• UTUC Recurrence Risk Lowered With Adjuvant Chemotherapy
• UTUC With Isolated Lymph Node Involvement Predicts Poor Survival
• UVADEX
• VALCHLOR
• VALSTAR
• VELCADE
• VENCLEXTA
• VERZENIO
• VIDAZA
• Vinblastine For Injection
• Vinblastine Injection
• Vincristine Sulfate PFS
• Vinorelbine
• VITRAKVI
• VITRAKVI ORAL SOLUTION
• VIZIMPRO
• VONJO
• VORAXAZE
• VOTRIENT
• VYXEOS
• WELIREG
• XALKORI
• XATMEP
• XELODA
• XERMELO
• XGEVA
• XOFIGO
• XOSPATA
• XPOVIO
• XTANDI
• YERVOY
• YESCARTA
• YONDELIS
• YONSA
• ZANOSAR
• ZEJULA
• ZELBORAF
• ZEPZELCA
• ZEVALIN
• ZINECARD
• ZIRABEV
• ZOLADEX
• ZOLADEX 3-MONTH 10.8mg
• ZOLINZA
• ZOMETA
• ZYDELIG
• ZYKADIA
• ZYNLONTA
• ZYTIGA